TripSitter Clinic Ltd.
TripSitter Clinic Ltd. Fundamental Analysis
TripSitter Clinic Ltd. (TSTTF) shows weak financial fundamentals with a PE ratio of 13.01, profit margin of 0.00%, and ROE of -1.84%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 28.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze TSTTF's fundamental strength across five key dimensions:
Efficiency Score
ExcellentTSTTF demonstrates superior asset utilization.
Valuation Score
ExcellentTSTTF trades at attractive valuation levels.
Growth Score
WeakTSTTF faces weak or negative growth trends.
Financial Health Score
ModerateTSTTF shows balanced financial health with some risks.
Profitability Score
WeakTSTTF struggles to sustain strong margins.
Key Financial Metrics
Is TSTTF Expensive or Cheap?
P/E Ratio
TSTTF trades at 13.01 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, TSTTF's PEG of 0.05 indicates potential undervaluation.
Price to Book
The market values TripSitter Clinic Ltd. at -0.24 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -12.32 times EBITDA. This is generally considered low.
How Well Does TSTTF Make Money?
Net Profit Margin
For every $100 in sales, TripSitter Clinic Ltd. keeps $0.00 as profit after all expenses.
Operating Margin
Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-1.84 in profit for every $100 of shareholder equity.
ROA
TripSitter Clinic Ltd. generates $25.64 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $-0.00 in free cash annually.
FCF Yield
TSTTF converts -13.26% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
13.01
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.05
vs 25 benchmark
P/B Ratio
Price to book value ratio
-0.24
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
-0.48
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.001
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.02
vs 25 benchmark
ROA
Return on assets percentage
25.64
vs 25 benchmark
ROCE
Return on capital employed
0.14
vs 25 benchmark
How TSTTF Stacks Against Its Sector Peers
| Metric | TSTTF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 13.01 | 29.06 | Better (Cheaper) |
| ROE | -1.84% | 646.00% | Weak |
| Net Margin | 0.00% | -44088.00% (disorted) | Weak |
| Debt/Equity | -0.48 | 0.33 | Strong (Low Leverage) |
| Current Ratio | 0.00 | 4.49 | Weak Liquidity |
| ROA | 2563.88% | -15444.00% (disorted) | Strong |
TSTTF outperforms its industry in 3 out of 6 key metrics, particularly excelling in ROA, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews TripSitter Clinic Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation